These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36232664)

  • 1. Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19.
    Boldova AE; Korobkin JD; Nechipurenko YD; Sveshnikova AN
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection.
    Okuya K; Hattori T; Saito T; Takadate Y; Sasaki M; Furuyama W; Marzi A; Ohiro Y; Konno S; Hattori T; Takada A
    Microbiol Spectr; 2022 Apr; 10(2):e0155321. PubMed ID: 35319248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.
    Ricke DO
    Front Immunol; 2021; 12():640093. PubMed ID: 33717193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
    Arvin AM; Fink K; Schmid MA; Cathcart A; Spreafico R; Havenar-Daughton C; Lanzavecchia A; Corti D; Virgin HW
    Nature; 2020 Aug; 584(7821):353-363. PubMed ID: 32659783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.
    Maemura T; Kuroda M; Armbrust T; Yamayoshi S; Halfmann PJ; Kawaoka Y
    mBio; 2021 Oct; 12(5):e0198721. PubMed ID: 34579572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.
    Ulrich H; Pillat MM; Tárnok A
    Cytometry A; 2020 Jul; 97(7):662-667. PubMed ID: 32506725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
    Farouq MAH; Acevedo R; Ferro VA; Mulheran PA; Al Qaraghuli MM
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
    Ziganshina MM; Shilova NV; Khalturina EO; Dolgushina NV; V Borisevich S; Yarotskaya EL; Bovin NV; Sukhikh GT
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection.
    García-Nicolás O; V'kovski P; Zettl F; Zimmer G; Thiel V; Summerfield A
    Front Cell Infect Microbiol; 2021; 11():644574. PubMed ID: 33912475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction.
    Wang S; Wang J; Yu X; Jiang W; Chen S; Wang R; Wang M; Jiao S; Yang Y; Wang W; Chen H; Chen B; Gu C; Liu C; Wang A; Wang M; Li G; Guo C; Liu D; Zhang J; Zhang M; Wang L; Gui X
    Commun Biol; 2022 Mar; 5(1):262. PubMed ID: 35332252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
    Jiang W; Wang J; Jiao S; Gu C; Xu W; Chen B; Wang R; Chen H; Xie Y; Wang A; Li G; Zeng D; Zhang J; Zhang M; Wang S; Wang M; Gui X
    MAbs; 2021; 13(1):1953683. PubMed ID: 34313527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
    Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD
    Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2.
    Yang Y; Xu F
    Front Immunol; 2022; 13():1008285. PubMed ID: 36330519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
    Zanella I; Degli Antoni M; Marchese V; Castelli F; Quiros-Roldan E
    Int Immunopharmacol; 2022 Sep; 110():108943. PubMed ID: 35753123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
    Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
    Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
    Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody Dependent Enhancement of SARS-CoV-2 Infection in the Era of Rapid Vaccine Development.
    Al Dossary R
    Med Arch; 2022 Oct; 76(5):383-386. PubMed ID: 36545460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling the dynamics of SARS-CoV-2 infection with antibody-dependent enhancement.
    Song H; Yuan Z; Liu S; Jin Z; Sun G
    Nonlinear Dyn; 2023; 111(3):2943-2958. PubMed ID: 36246668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19.
    Matveev A; Pyankov O; Khlusevich Y; Tyazhelkova O; Emelyanova L; Timofeeva A; Shipovalov A; Chechushkov A; Zaitseva N; Kudrov G; Yusubalieva G; Yussubaliyeva S; Zhukova O; Baklaushev V; Sedykh S; Lifshits G; Tikunov A; Tikunova N
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.
    Yip MS; Leung NH; Cheung CY; Li PH; Lee HH; Daëron M; Peiris JS; Bruzzone R; Jaume M
    Virol J; 2014 May; 11():82. PubMed ID: 24885320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.